NCT06612970View on ClinicalTrials.gov

A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

June 13, 2025

Study Completion Date

October 1, 2025

Conditions

Healthy

Interventions

DRUG

HB0056

HB0056 Injection

DRUG

Placebo

Placebo

Trial Locations (1)

8011

RECRUITING

New Zealand Clinical Research, Christchurch

All Listed Sponsors

lead

Shanghai Huaota Biopharmaceutical Co., Ltd.

INDUSTRY